Pharsight

Medicines360 patents expiration

1. Liletta patents expiration

LILETTA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11090186 MEDICINES360 Methods for using intrauterine systems and IUD insertion devices
Oct, 2033

(9 years from now)

US10028858 MEDICINES360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Mar, 2034

(9 years from now)

US11571328 MEDICINES360 NA
Sep, 2040

(16 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication (I) Jun 29, 2026

Drugs and Companies using LEVONORGESTREL ingredient

Market Authorisation Date: 26 February, 2015

Treatment: A method for prevention of pregnancy

Dosage: INTRAUTERINE DEVICE;INTRAUTERINE

More Information on Dosage

LILETTA family patents

Family Patents